Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Charles Theuer
AddedMar 31, 2024
UpdatedMay 31, 2026
Charles Theuer

Charles Theuer

Board Member, 4D Molecular Therapeutics

LinkedIn

Charles Theuer's Career

4D Molecular Therapeutics
4D Molecular Therapeutics

Emeryville, CA, US

Board Member· Board
Tracon Pharmaceuticals
Tracon Pharmaceuticals

San Diego, CA, US

Board Member· Board
Oncternal Therapeutics
Oncternal Therapeutics

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Charles Theuer's Career

4D Molecular Therapeutics
4D Molecular Therapeutics
Public$295M1402013Emeryville, CA, US
Board Member· Board

Leadership at 4D Molecular Therapeutics

David KirnDavid KirnBoard Member
Theresa JankeTheresa JankeCo-Founder
David SchafferDavid SchafferCo-Founder
Jacob ChackoJacob ChackoBoard Member
Shawn TomaselloShawn TomaselloBoard Member
John F. MilliganJohn F. MilliganBoard Member

Similar to 4D Molecular Therapeutics

C4 TherapeuticsC4 TherapeuticsCambridge, MA, USCancer Therapiesest. 2015C4 TherapeuticsCambridge, MA, US · est. 2015

C4 Therapeutics, a US biotech firm, innovates early-stage therapies to treat cancer and neurological diseases.

Public · $298.8M146
Intergalactic TherapeuticsIntergalactic TherapeuticsCambridge, MA, USGene Therapyest. 2020Intergalactic TherapeuticsCambridge, MA, US · est. 2020

Intergalactic Therapeutics: Pioneering the future of non-viral gene therapy for patients.

Series A · $75M41
Solid BiosciencesSolid BiosciencesCambridge, MA, USGene Therapy, Therapiesest. 2013Solid BiosciencesCambridge, MA, US · est. 2013

Solid Biosciences Inc., a US-based biotech firm, develops therapies and devices for muscular dystrophy.

Public · $441.3M87
Tracon Pharmaceuticals
Tracon Pharmaceuticals
Public$113M182004San Diego, CA, US
Board Member· Board

Leadership at Tracon Pharmaceuticals

William R. LaRueWilliam R. LaRueBoard Member
Alfred ScheideggerAlfred ScheideggerBoard Member
Martin MattinglyMartin MattinglyBoard Member
Bertrand LiangBertrand LiangBoard Member
Carol C LamCarol C LamBoard Member
William 'Bill' L. Armstrong, MAIWilliam 'Bill' L. Armstrong, MAIBoard Member

Similar to Tracon Pharmaceuticals

Tallac TherapeuticsTallac TherapeuticsBurlingame, CA, USCancer Treatments, Immunotherapyest. 2018Tallac TherapeuticsBurlingame, CA, US · est. 2018

Tallac Therapeutics: A biopharmaceutical firm innovating cancer immunotherapy treatments.

Series A · $88.2M34
Tract TherapeuticsTract TherapeuticsChicago, IL, USMedicalest. 2013Tract TherapeuticsChicago, IL, US · est. 2013

Nova Biomedical: Innovating immune balance restoration for solid organ transplant patients.

Series B · $15M5
Crinetics PharmaceuticalsCrinetics PharmaceuticalsSan Diego, CA, USTherapeuticsest. 2008Crinetics PharmaceuticalsSan Diego, CA, US · est. 2008

San Diego-based Crinetics Pharmaceuticals develops therapeutics for endocrine diseases and cancers.

Public · $796M210
Oncternal Therapeutics
Oncternal Therapeutics
Public$132M302013San Diego, CA, US
Board Member· Board

Leadership at Oncternal Therapeutics

Lauren OtsukiLauren OtsukiFounder
Michael G. CarterMichael G. CarterBoard Member
Daniel KisnerDaniel KisnerBoard Member
Cam GallagherCam GallagherBoard Member
David F. HaleDavid F. HaleBoard Member
Scott GlennScott GlennBoard Member

Charles Theuer's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Charles Theuer

M. Gayle PackerM. Gayle PackerCEO · TerraconDennis E. McGuireDennis E. McGuireBoard Member · Ecosphere TechnologiesSpencer LakeSpencer LakeBoard Member · nCinoDrew MoynihanDrew MoynihanBoard Member · SkaffolderColin WielColin WielFounder · Waypoint CapitalBruno JactelBruno JactelBoard Member · Hypercell Technologies